{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:33:43Z","timestamp":1790332423436,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jpedsurg.2019.09.029","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T12:57:04Z","timestamp":1571662624000},"page":"1941-1946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["In utero treatment of myelomeningocele with placental mesenchymal stromal cells \u2014 Selection of an optimal cell line in preparation for clinical trials"],"prefix":"10.1016","volume":"55","author":[{"given":"Laura A","family":"Galganski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarsini","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A","family":"Vanover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D","family":"Pivetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie E","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Lankford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary J","family":"Paxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mennatalla S","family":"Hegazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaeli J","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpedsurg.2019.09.029_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.siny.2009.05.002","article-title":"Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention","volume":"15","author":"Adzick","year":"2010","journal-title":"Semin Fetal Neonatal Med"},{"issue":"11","key":"10.1016\/j.jpedsurg.2019.09.029_bb0010","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1014379","article-title":"A randomized trial of prenatal versus postnatal repair of myelomeningocele","volume":"364","author":"Adzick","year":"2011","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jpedsurg.2019.09.029_bb0015","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/bdr2.1094","article-title":"Apoptosis, expression of PAX3 and P53, and caspase signal in fetuses with neural tube defects","volume":"109","author":"Wang","year":"2017","journal-title":"Birth defects research"},{"issue":"9","key":"10.1016\/j.jpedsurg.2019.09.029_bb0020","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jpedsurg.2007.04.019","article-title":"Scanning electron microscopy of fetal murine myelomeningocele reveals growth and development of the spinal cord in early gestation and neural tissue destruction around birth","volume":"42","author":"Stiefel","year":"2007","journal-title":"J Pediatr Surg"},{"issue":"8","key":"10.1016\/j.jpedsurg.2019.09.029_bb0025","article-title":"Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis","volume":"8","author":"Hsieh","year":"2013","journal-title":"and angiogenesis PloS one"},{"issue":"10","key":"10.1016\/j.jpedsurg.2019.09.029_bb0030","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jpedsurg.2019.09.029_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5966\/sctm.2014-0296","article-title":"Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jpedsurg.2019.09.029_bb0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2012.12.038","article-title":"Neurorescue effects and stem properties of chorionic villi and amniotic progenitor cells","volume":"234","author":"Calzarossa","year":"2013","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jpedsurg.2019.09.029_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/14653249.2011.613928","article-title":"Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress","volume":"14","author":"Yust-Katz","year":"2012","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.jpedsurg.2019.09.029_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000433427","article-title":"Age does matter: a pilot comparison of placenta-derived stromal cells for in utero repair of myelomeningocele using a lamb model","volume":"39","author":"Brown","year":"2016","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"10.1016\/j.jpedsurg.2019.09.029_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpedsurg.2017.10.032","article-title":"Placental mesenchymal stromal cells seeded on clinical grade extracellular matrix improve ambulation in ovine myelomeningocele","volume":"53","author":"Kabagambe","year":"2018","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.jpedsurg.2019.09.029_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpedsurg.2017.10.040","article-title":"Fetal surgical repair with placenta-derived mesenchymal stromal cell engineered patch in a rodent model of myelomeningocele","volume":"53","author":"Chen","year":"2018","journal-title":"J Pediatr Surg"},{"issue":"3","key":"10.1016\/j.jpedsurg.2019.09.029_bb0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3727\/096368915X686922","article-title":"Transplantation of human placenta-derived multipotent stem cells reduces ischemic brain injury in adult rats","volume":"24","author":"Wu","year":"2015","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.jpedsurg.2019.09.029_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v7.i1.195","article-title":"Early gestation chorionic villi-derived stromal cells for fetal tissue engineering","volume":"7","author":"Lankford","year":"2015","journal-title":"World journal of stem cells"},{"issue":"9","key":"10.1016\/j.jpedsurg.2019.09.029_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043395","article-title":"Ontological differences in first compared to third trimester human fetal placental chorionic stem cells","volume":"7","author":"Jones","year":"2012","journal-title":"PloS one"},{"issue":"7","key":"10.1016\/j.jpedsurg.2019.09.029_bb0080","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/14653240802419310","article-title":"Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta","volume":"10","author":"Poloni","year":"2008","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.jpedsurg.2019.09.029_bb0085","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jcyt.2016.06.002","article-title":"Neuroprotective effects of placenta-derived mesenchymal stromal cells in a rat model of experimental autoimmune encephalomyelitis","volume":"18","author":"Selim","year":"2016","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jpedsurg.2019.09.029_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4252\/wjsc.v4.i6.53","article-title":"Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue","volume":"4","author":"Vellasamy","year":"2012","journal-title":"World journal of stem cells."},{"issue":"2","key":"10.1016\/j.jpedsurg.2019.09.029_bb0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.intimp.2012.03.024","article-title":"Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells","volume":"13","author":"Lee","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.jpedsurg.2019.09.029_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpedsurg.2018.10.032","article-title":"High density placental mesenchymal stromal cells provide neuronal preservation and improve motor function following in utero treatment of ovine myelomeningocele","volume":"54","author":"Vanover","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"7","key":"10.1016\/j.jpedsurg.2019.09.029_bb0105","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcyt.2017.03.076","article-title":"Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy","volume":"19","author":"de Wolf","year":"2017","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.jpedsurg.2019.09.029_bb0110","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/sctm.17-0129","article-title":"Multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine","volume":"6","author":"Samsonraj","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.jpedsurg.2019.09.029_bb0115","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/stem.1982","article-title":"Establishing criteria for human mesenchymal stem cell potency","volume":"33","author":"Samsonraj","year":"2015","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"2","key":"10.1016\/j.jpedsurg.2019.09.029_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","volume":"18","year":"2016","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jpedsurg.2019.09.029_bb0125","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1096\/fj.201800972R","article-title":"Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes","volume":"33","author":"Kumar","year":"2019","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.jpedsurg.2019.09.029_bb0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2016.12","article-title":"Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington's disease mouse models","volume":"24","author":"Pollock","year":"2016","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"issue":"6","key":"10.1016\/j.jpedsurg.2019.09.029_bb0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcyt.2017.03.003","article-title":"Manufacture and preparation of human placenta-derived mesenchymal stromal cells for local tissue delivery","volume":"19","author":"Lankford","year":"2017","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jpedsurg.2019.09.029_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12640-012-9311-1","article-title":"Evaluation of the neurotoxic\/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine","volume":"22","author":"Lopes","year":"2012","journal-title":"Neurotox Res"},{"issue":"7","key":"10.1016\/j.jpedsurg.2019.09.029_bb0145","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jpedsurg.2014.10.021","article-title":"Innate healing in the fetal sheep model of myelomeningocele: a standardized defect grading system","volume":"50","author":"Brown","year":"2015","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.jpedsurg.2019.09.029_bb0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpedsurg.2015.01.002","article-title":"Development of a locomotor rating scale for testing motor function in sheep","volume":"50","author":"Brown","year":"2015","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2019.09.029_bb0155","first-page":"1","article-title":"Spinal angulation: a limitation of the fetal lamb model of myelomeningocele","author":"Vanover","year":"2019","journal-title":"Fetal diagnosis and therapy"},{"issue":"5","key":"10.1016\/j.jpedsurg.2019.09.029_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmed.2010.02.005","article-title":"Mesenchymal stem cell therapy: two steps forward, one step back","volume":"16","author":"Ankrum","year":"2010","journal-title":"Trends Mol Med"},{"issue":"8","key":"10.1016\/j.jpedsurg.2019.09.029_bb0165","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/stem.459","article-title":"Concise review: hitting the right spot with mesenchymal stromal cells","volume":"28","author":"Tolar","year":"2010","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"5","key":"10.1016\/j.jpedsurg.2019.09.029_bb0170","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/scd.2009.0345","article-title":"Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders","volume":"19","author":"Zhao","year":"2010","journal-title":"Stem Cells Dev"},{"issue":"4","key":"10.1016\/j.jpedsurg.2019.09.029_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.jpedsurg.2019.09.029_bb0180","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrcardio.2013.94","article-title":"Vascular endothelial growth factor in heart failure","volume":"10","author":"Taimeh","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.jpedsurg.2019.09.029_bb0185","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nn.3109","article-title":"Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models","volume":"15","author":"Bai","year":"2012","journal-title":"Nat Neurosci"},{"issue":"Pt 15","key":"10.1016\/j.jpedsurg.2019.09.029_bb0190","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1242\/jcs.00610","article-title":"Regulation of keratinocyte shape, migration and wound epithelialization by IGF-1- and EGF-dependent signalling pathways","volume":"116","author":"Haase","year":"2003","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.jpedsurg.2019.09.029_bb0195","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0896-6273(00)80247-0","article-title":"Hepatocyte growth factor\/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons","volume":"17","author":"Ebens","year":"1996","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.jpedsurg.2019.09.029_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110324","article-title":"Neurotrophic requirements of human motor neurons defined using amplified and purified stem cell-derived cultures","volume":"9","author":"Lamas","year":"2014","journal-title":"PloS one."},{"issue":"3","key":"10.1016\/j.jpedsurg.2019.09.029_bb0205","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2009.10.058","article-title":"Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair","volume":"390","author":"Zisa","year":"2009","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346819306815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346819306815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:37:25Z","timestamp":1758357445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346819306815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0022346819306815"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2019.09.029","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In utero treatment of myelomeningocele with placental mesenchymal stromal cells \u2014 Selection of an optimal cell line in preparation for clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2019.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}